NQMC Update Service: September 29, 2014 ▲ European Surveillance of Antimicrobial Consumption Network

NQMC Update Service: September 29, 2014

European Surveillance of Antimicrobial Consumption Network

• Disease-specific antibiotic prescribing: percentage of female patients older than 18 years with cystitis/other urinary infection prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of female patients older than 18 years with cystitis/other urinary infection prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of female patients older than 18 years with cystitis/other urinary infection prescribed antibacterials for systemic use.

• Disease-specific antibiotic prescribing: percentage of patients aged between 18 and 65 years with pneumonia prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of patients aged between 18 and 65 years with pneumonia prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of patients aged between 18 and 65 years with pneumonia prescribed antibacterials for systemic use.

• Disease-specific antibiotic prescribing: percentage of patients aged between 18 and 75 years with acute bronchitis/bronchiolitis prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of patients aged between 18 and 75 years with acute bronchitis/bronchiolitis prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of patients aged between 18 and 75 years with acute bronchitis/bronchiolitis prescribed antibacterials for systemic use.

• Disease-specific antibiotic prescribing: percentage of patients older than 1 year with acute tonsillitis prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of patients older than 1 year with acute tonsillitis prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of patients older than 1 year with acute tonsillitis prescribed antibacterials for systemic use.

• Disease-specific antibiotic prescribing: percentage of patients older than 1 year with acute upper respiratory infection prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of patients older than 1 year with acute upper respiratory infection prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of patients older than 1 year with acute upper respiratory infection prescribed antibacterials for systemic use.

• Disease-specific antibiotic prescribing: percentage of patients older than 18 years with acute/chronic sinusitis prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of patients older than 18 years with acute/chronic sinusitis prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of patients older than 18 years with acute/chronic sinusitis prescribed antibacterials for systemic use.

• Disease-specific antibiotic prescribing: percentage of patients older than 2 years with acute otitis media/myringitis prescribed antibacterials for systemic use receiving quinolones.

• Disease-specific antibiotic prescribing: percentage of patients older than 2 years with acute otitis media/myringitis prescribed antibacterials for systemic use receiving the recommended antibacterials.

• Disease-specific antibiotic prescribing: percentage of patients older than 2 years with acute otitis media/myringitis prescribed antibacterials for systemic use.